- Home
- IMAB vs GHG Comparison
IMAB vs GHG Comparison
Compare IMAB & GHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAB
- GHG
- Stock Information
- Founded
- IMAB 2014
- GHG 2004
- Country
- IMAB United States
- GHG China
- Employees
- IMAB N/A
- GHG N/A
- Industry
- IMAB Biotechnology: Pharmaceutical Preparations
- GHG Hotels/Resorts
- Sector
- IMAB Health Care
- GHG Consumer Discretionary
- Exchange
- IMAB Nasdaq
- GHG Nasdaq
- Market Cap
- IMAB 200.9M
- GHG 202.0M
- IPO Year
- IMAB 2020
- GHG 2018
- Fundamental
- Price
- IMAB $2.29
- GHG $2.42
- Analyst Decision
- IMAB Strong Buy
- GHG
- Analyst Count
- IMAB 2
- GHG 0
- Target Price
- IMAB $6.00
- GHG N/A
- AVG Volume (30 Days)
- IMAB 1.0M
- GHG 12.9K
- Earning Date
- IMAB 05-15-2025
- GHG 08-14-2025
- Dividend Yield
- IMAB N/A
- GHG 4.74%
- EPS Growth
- IMAB N/A
- GHG N/A
- EPS
- IMAB N/A
- GHG 0.15
- Revenue
- IMAB N/A
- GHG $184,055,595.00
- Revenue This Year
- IMAB N/A
- GHG $19.02
- Revenue Next Year
- IMAB N/A
- GHG $8.26
- P/E Ratio
- IMAB N/A
- GHG $14.22
- Revenue Growth
- IMAB N/A
- GHG N/A
- 52 Week Low
- IMAB $0.60
- GHG $1.93
- 52 Week High
- IMAB $3.08
- GHG $3.40
- Technical
- Relative Strength Index (RSI)
- IMAB 53.66
- GHG 70.86
- Support Level
- IMAB $2.00
- GHG $1.97
- Resistance Level
- IMAB $2.95
- GHG $2.13
- Average True Range (ATR)
- IMAB 0.35
- GHG 0.12
- MACD
- IMAB -0.07
- GHG 0.03
- Stochastic Oscillator
- IMAB 30.53
- GHG 93.65
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).
About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.